Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Clinical Trials

Psychedelic clinical trials, tracked end to end

Every psilocybin, MDMA, ketamine and DMT trial — from Phase I to approval. Filter by phase, status, indication and sponsor to see where the field is really moving.

The psychedelic pipeline, in one place

Blossom tracks every psychedelic clinical trial globally — recruitment status, protocol changes, interim results and final read-outs — synthesised daily from ClinicalTrials.gov, the EU CTR and beyond.

Phase-by-phase progression

See which compounds are moving through Phase I, II and III, which are stalling, and which are approaching regulatory decisions.

Sponsors, sites and stakeholders

Every trial linked to the sponsor running it, the sites recruiting, and the compounds being tested. Map the competitive landscape in minutes.

Recruiting, right now

Filter for trials actively enrolling by indication and location — so patients, referrers and researchers find open studies fast.

Analysis

Research Snapshot

View a high-level snapshot of psychedelic research across topics, including total trials, participants, papers, pipeline distribution, and citation network patterns.

Open Snapshot